A TLR7 agonist, Imiquimod (IMQ)-induced SLE mouse model (13) was used to explore the pathogenesis of immune complex-mediated lupus nephritis in several previous reports (14, 15). This evidence concerns the gene TLR7 and systemic lupus erythematosus.